Low-grade serous ovarian cancer: A review
详细信息 查看全文
- 作者：Anis Kaldawya ; b ; Yakir Segeva ; b ; Ofer Laviea ; b ; Ron Auslendera ; b ; Victoria Sopikc ; Steven A. Narodc ; steven.narod@wchospital.ca" class="auth_mail" title="E-mail the corresponding author
- 关键词：Epithelial ovarian cancer ; Low-grade serous ovarian cancer ; High-grade serous ovarian cancer ; MAPK inhibitors ; BRAF mutations
- 刊名：Gynecologic Oncology
- 出版年：2016
- 出版时间：November 2016
- 年：2016
- 卷：143
- 期：2
- 页码：433-438
- 全文大小：221 K
文摘
- •
The presence of a BRAF mutation in a serous borderline tumour may protect against progression to low-grade serous cancer
- •
The presence of a KRAS mutation in a low-grade serous tumour may be a good prognostic factor
- •
The most important prognostic factor in patients with low-grade cancer is the amount of residual disease post-surgery